Avalo Therapeutics (AVTX) EBT Margin (2016 - 2025)
Avalo Therapeutics' EBT Margin came in at -23033.90% for Q4 2025, down 4687.54 percentage points from -18346.35% a year earlier.
Powered by 
Analysis
Avalo Therapeutics (AVTX) EBT Margin (2016 - 2025) Analysis & Trends
For FY2025, Avalo Therapeutics' EBT Margin was -132362.71%, down 124422.80 percentage points from FY2024.
- EBT Margin has declined in each of the last three years, with a five-year change of -131359.92 percentage points (FY2020 to FY2025).
- Going back by year, EBT Margin was -7939.91% in FY2024 (-6301.14 pp), -1638.77% in FY2023 (-1408.15 pp), -230.62% in FY2022 (+1335.60 pp) and -1566.23% in FY2021 (-563.44 pp).
- The Q4 2025 figure represents the lowest quarterly EBT Margin in data going back to Q3 2016.
- The fastest year-over-year change in EBT Margin over five years came in Q3 2024 (a gain of 11458.05 percentage points), and the weakest in Q4 2024 (a drop of 16914.31 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Avalo Therapeutics | 657.52 Mn | 657.52 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -23,033.90% |
| Dec 31, 2024 | -18,346.35% |
| Sep 30, 2024 | 9,246.18% |
| Dec 31, 2023 | -1,432.05% |
| Sep 30, 2023 | -2,211.86% |
| Jun 30, 2023 | -1,273.09% |
| Mar 31, 2023 | -2,094.11% |
| Dec 31, 2022 | -1,094.20% |
| Sep 30, 2022 | 21.39% |
| Jun 30, 2022 | -1,256.73% |
| Mar 31, 2022 | -1,879.11% |
| Dec 31, 2021 | -8,742.92% |
| Sep 30, 2021 | -1,293.56% |
| Jun 30, 2021 | -517.82% |
| Mar 31, 2021 | -6,461.52% |
| Dec 31, 2020 | -1,090.71% |
| Sep 30, 2020 | -1,193.34% |
| Jun 30, 2020 | -992.53% |
| Mar 31, 2020 | -882.79% |
| Dec 31, 2019 | -974.36% |
API Access
Avalo Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();